Lupin unveils heart drug Rivaroxaban in US Ruchika Sharma8 March 2025 11:41 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of...
Lupin secures place in Prestigious S&P Global Sustainability Yearbook 2025 Ruchika Sharma2 March 2025 2:00 PM ISTMumbai: Global pharma major Lupin Limited has announced its inclusion in prestigious S&P Global Sustainability Yearbook 2025, for the second...
Lupin Gets Rs 18 Crore Relief as HC Bars Arbitrary Tax Reassessment Farhat Nasim22 Feb 2025 4:28 PM ISTMumbai: In a major relief to pharma giant Lupin Limited, the Bombay High Court has quashed a reassessment notice issued under Section 148 of the...
USFDA issues EIR for Lupin Somerset facility Ruchika Sharma22 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has issued the...
Lupin bags USFDA nod for Ipratropium Bromide Nasal Solution for rhinorrhea Ruchika Sharma11 Feb 2025 10:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...
Natco Pharma gets final approval for Bosentan tablets for oral suspension Ruchika Sharma10 Feb 2025 11:30 AM ISTHyderabad: NATCO Pharma Limited has announced final approval of its Abbreviated New Drug Application (ANDA) for Bosentan tablets for oral...
Sun Pharma to pay Rs 160.2 crore penalty, tops list of 6 drug majors facing tax scrutiny Farhat Nasim7 Feb 2025 7:31 PM ISTNew Delhi: Six leading pharmaceutical companies, Sun Pharmaceutical Industries, Ipca Laboratories, Indoco Remedies, Aurobindo Pharma, Lupin Limited,...
Lupin bags tentative USFDA okay for generic HIV Medication Ruchika Sharma4 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
USFDA completes inspection of Lupin Somerset facility with no observations Ruchika Sharma3 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a Pre-Approval...
Lupin's Generic Entresto Approved by USFDA, Set to Rival Novartis' Bestseller Farhat Nasim29 Jan 2025 8:04 PM ISTMumbai: In a fresh challenge to Novartis' blockbuster heart failure drug Entresto, Indian generics maker Lupin has received approval from the U.S....
USFDA nod to Lupin Ipratropium Bromide Nasal Solution for runny nose Ruchika Sharma29 Jan 2025 3:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
Lupin, Avas unveil myotonia treatment NaMuscla in Italy Ruchika Sharma29 Jan 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited and Avas Pharmaceuticals SRL have announced the launch of Lupin's orphan drug NaMuscla (mexiletine) in...
